Terms: = Pancreatic cancer AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729 AND Prognosis
14 results:
1. The Senescence-Related Signature Predicts prognosis and Characterization of Tumor Microenvironment Infiltration in pancreatic cancer.
Hua H; Zheng C; Fan J; Li X; Xie W; Chen J; Yu C
Biomed Res Int; 2022; 2022():1916787. PubMed ID: 36518628
[TBL] [Abstract] [Full Text] [Related]
2. Predictors of post-recurrence survival in hepatocellular carcinoma patients following liver transplantation: Systematic review and meta-analysis.
Al-Ameri A; Yu X; Zheng S
Transplant Rev (Orlando); 2022 Jan; 36(1):100676. PubMed ID: 34999555
[TBL] [Abstract] [Full Text] [Related]
3. Loss of ATRX expression predicts worse prognosis in pulmonary carcinoid tumors.
Terra Md SBSP; Xie Md PhD H; Boland Md JM; Mansfield Md AS; Molina Md PhD JR; Roden Md AC
Hum Pathol; 2019 Dec; 94():78-85. PubMed ID: 31499081
[TBL] [Abstract] [Full Text] [Related]
4. High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma.
Zhou CY; Dong YP; Sun X; Sui X; Zhu H; Zhao YQ; Zhang YY; Mason C; Zhu Q; Han SX
Cancer Med; 2018 Nov; 7(11):5525-5533. PubMed ID: 30358133
[TBL] [Abstract] [Full Text] [Related]
5. MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinoma.
Li C; Dong Q; Che X; Xu L; Li Z; Fan Y; Hou K; Wang S; Qu J; Xu L; Wen T; Yang X; Qu X; Liu Y
BMC Cancer; 2018 Jun; 18(1):681. PubMed ID: 29940895
[TBL] [Abstract] [Full Text] [Related]
6. miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting cblb/GRB2 in breast cancer cells.
Chen D; Si W; Shen J; Du C; Lou W; Bao C; Zheng H; Pan J; Zhong G; Xu L; Fu P; Fan W
Cell Death Dis; 2018 Feb; 9(2):188. PubMed ID: 29416005
[TBL] [Abstract] [Full Text] [Related]
7. Radiofrequency ablation for hepatic oligometastatic pancreatic cancer: An analysis of safety and efficacy.
Hua YQ; Wang P; Zhu XY; Shen YH; Wang K; Shi WD; Lin JH; Meng ZQ; Chen Z; Chen H
Pancreatology; 2017; 17(6):967-973. PubMed ID: 29129384
[TBL] [Abstract] [Full Text] [Related]
8. Predictive Value of Serum Carbohydrate Antigen 19-9 (CA19-9) for Early Mortality in Advanced pancreatic cancer.
Usón Junior PLS; Callegaro-Filho D; Bugano DDG; Moura F; Maluf FC
J Gastrointest Cancer; 2018 Dec; 49(4):481-486. PubMed ID: 28924968
[TBL] [Abstract] [Full Text] [Related]
9. Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.
Tang H; Wei P; Chang P; Li Y; Yan D; Liu C; Hassan M; Li D
Int J Cancer; 2017 Aug; 141(4):678-686. PubMed ID: 28470677
[TBL] [Abstract] [Full Text] [Related]
10. MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting Cbl-b to suppress the growth of pancreatic cancer cells.
Dong Q; Li C; Che X; Qu J; Fan Y; Li X; Li Y; Wang Q; Liu Y; Yang X; Qu X
Oncotarget; 2016 Dec; 7(50):82338-82353. PubMed ID: 27494897
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer.
Geng Y; Qi Q; Sun M; Chen H; Wang P; Chen Z
Eur J Surg Oncol; 2015 Nov; 41(11):1508-14. PubMed ID: 26343824
[TBL] [Abstract] [Full Text] [Related]
12. Serum carbohydrate antigen 242 expression exerts crucial function in the diagnosis of pancreatic cancer.
Li X; Guo X; Li H; Lin H; Sun Y
Tumour Biol; 2014 Jun; 35(6):5281-6. PubMed ID: 24510349
[TBL] [Abstract] [Full Text] [Related]
13. The incidence and survival rate of population-based pancreatic cancer patients: Shanghai cancer Registry 2004-2009.
Luo J; Xiao L; Wu C; Zheng Y; Zhao N
PLoS One; 2013; 8(10):e76052. PubMed ID: 24130758
[TBL] [Abstract] [Full Text] [Related]
14. CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis.
Gui JC; Yan WL; Liu XD
Clin Exp Med; 2014 May; 14(2):225-33. PubMed ID: 23456571
[TBL] [Abstract] [Full Text] [Related]
